Estimation of Creatinine Clearance from Serum Creatinine Concentration — A Review

Giusti D. L. Hayton W. L. : Dosage Regimen Adjustments in Renal Impairment, Drug Intell. Clin. Pharm. 7: 382–387 (Sept.) 1973.

Tozer T. N. : Nomogram for Modification of Dosage Regimens in Patients with Chronic Renal Function Impairment. J. Pharmacokinet. Biopharm. 2: 13–28 (Feb.) 1974.

Dettli L. : Individualization of Drug Dosage in Patients with Renal Disease, Med. Clin. North Am. 58: 977–985 (Sept.) 1974.

Jelliffe R. W. : An Improved Method of Digoxin Therapy, Ann. Intern. Med. 69: 703–717 (Oct.) 1968.

Welling P. G. Craig W. A. Kunin C. M. : Prediction of Drug Dosage in Patients with Renal Failure Using Data Derived from Normal Subjects, Clin. Pharmacol. Ther. 17: 692–700 (June) 1975.

Siersbaek-Nielsen K. Hansen J. M. Kampmann J. Kristensen M. : Rapid Evaluation of Creatinine Clearance, Lancet 1: 1133–1134 (May 29) 1971.

Greenblatt D. J. Ransil B. J. Harmatz J. S. Smith T. W. Duhme D. W. Koch-Weser J. : Variability of 24-Hour Urinary Creatinine Excretion by Normal Subjects, J. Clin. Pharmacol. 16: 321–328 (July) 1976.

Jones J. D. Burnett P. C. : Creatinine Metabolism in Humans with Decreased Renal Function: Creatinine Deficit, Clin. Chem. 20: 1204–1212 (Sept.) 1974.

Dominguez R. : Kinetics of Elimination, Absorption and Volume of Distribution in the Organism, Med. Phys. 2: 476–489, 1950.

Brod J. Sirota J. H. : The Renal Clearance of Endogenous “Creatinine” in Man, J. Clin. Invest. 27: 645–654 (Sept.) 1948.

Dominguez R. Pomerene E. : Studies on the Renal Excretion of Creatinine I. On the Functional Relation Between the Rate of Output and the Concentration in the Plasma, J. Biol. Chem. 104: 449–471 (Mar.) 1934.

Chiou W. L. Hsu F. H. : Pharmacokinetics of Creatinine in Man and Its Implications in the Monitoring of Renal Function and in Dosage Regimen Modifications in Patients with Renal Insufficiency, J. Clin. Pharmacol. 15: 427–434 (May-June) 1975.

Dunea G. Freedman P. : Serum Creatinine, J. Am. Med. Assoc. 204: 163 (Apr. 8) 1968.

Henry J. B. : Clinical Chemistry, in Todd-Sanford Clinical Diagnosis by Laboratory Methods, 15th Ed., Davidsohn I. Henry J. B. (Eds.), W. B. Saunders, Philadelphia, p. 596, 1974.

Diem K. Lentner C. , (Eds.), Scientific Tables, 7th ed., Ciba-Geigy, Basle, pp. 531, 572, 1970.

Cockroft D. W. Gault M. H. : Prediction of Creatinine Clearance from Serum Creatinine, Nephron 16: 31–41 (No. 1), 1976.

Henry J. B. : Op. cit., p. 595.

Doolan P. D. Alpen E. L. Theil G. B. : A Clinical Appraisal of the Plasma Concentration and Endogenous Clearance of Creatinine, Am. J. Med. 32: 65–79 (Jan.) 1962.

Kristensen M. Hansen J. M. Kampmann J. Lumholtz B. Siersbaek-Nielsen K. : Drug Elimination and Renal Function, J. Clin. Pharmacol. 14: 307–308 (May-June) 1974.

Paper S. : The Effects of Age in Reducing Renal Function, Geriatrics 28: 83–87 (May) 1973.

Masarei J. R. L. : Validity of Corrections for Creatinine Excretion and Creatinine Clearance, N. Z. Med. J. 82: 197–198 (Sept. 24) 1975.

Tyler F. H. : Muscular Dystrophies, In The Metabolic Basis of Inherited Disease, 2nd ed., Stanbury J. B. Wyngaarden J. B. Frederickson D. S. (Eds.), McGraw-Hill, Blakiston Div., New York, New York, pp. 945–946, 1966.

Jelliffe R. W. : Estimation of Creatinine Clearance When Urine Cannot be Collected, Lancet 1: 975–976 (May 8) 1971.

Jelliffe R. W. Jelliffe S. M. : A Computer Program for Estimation of Creatinine Clearance from Unstable Serum Creatinine Concentration, Math. Biosci. 14: 17–24 (June) 1972.

Mawer G. E. Knowles B. R. Lucas S. B. Stirland R. M. Tooth J. A. : Computer-Assisted Prescribing of Kanamycin for Patients with Renal Insufficiency, Lancet 1: 12–15 (Jan. 1) 1972.

Mawer G. E. : Computer Assisted Prescribing of Drugs, Clin. Pharmacokinet. 1: 67–78 (Jan. Feb.) 1976.

Mawer G. E. Lucas S. B. McGough J. G. : Nomogram for Kanamycin Dosage, Lancet 2: 45 (July 1) 1972.

Mawer G. E. Ahmed R. Dobbs S. M. McGough J. G. Lucas S. B. Tooth J. A. : Prescribing Aids for Gentamicin, Br. J. Clin. Pharmacol. 1: 45–50 (Feb.) 1974.

Devine B. J. : Clinical Pharmacy Case Studies. Case Number 25: Gentamicin Therapy, Drug Intell. Clin. Pharm. 8: 650–655 (Nov.) 1974.

Hume R. : Prediction of Lean Body Mass from Height and Weight, J. Clin. Pathol. 19: 389 (July) 1966.

Kampmann J. Siersbaek-Nielsen J. M. : Rapid Evaluation of Creatinine Clearance, Acta Med. Scand. 196: 517–520 (Dec.) 1974.

Goldman R. : Creatinine Excretion in Renal Failure, Proc. Soc. Exp. Biol. Med. 85: 446–448 (Mar.) 1954.

Jelliffe R. W. : Creatinine Clearance: Bedside Estimate, Ann. Intern. Med. 79: 604–605 (Oct.) 1973.

Wagner J. G. : Bio pharmaceutics and Relevant Pharmacokinetics, 1st ed., Drug Intelligence Publications, Hamilton. IL 62341, pp. 222–233, 1971.

Schwartz G. J. Haycock G. B. Edelmann C. M. Spitzer A. : A Simple Estimate of Glomerular Filtration Rate in Children Derived from Body Length and Plasma Creatinine, Pediatrics 58: 259–263 (Aug.) 1976.

Kassirer J. P. : Clinical Evaluation of Kidney Function — Glomerular Function, N. Engl. J. Med. 285: 385–389 (Aug. 12) 1971.

Rowe J. M. Andres R. Tobin J. D. Norris A. H. Shock N. W. : Age-Adjusted Standards for Creatinine Clearance, Ann. Intern. Med. 84: 567–569 (May) 1976.

Boedeker E. C. Dauber J. C. : Manual of Medical Therapeutics, 21st ed., Little Brown and Company, Boston, MA p. 434, 1974.

Gehan E. A. George S. L. : Estimation of Human Body Surface Area from Height and Weight, Cancer Chemother. Rep. Part I 54: 225–235 (Aug.) 1970.

Bryan C. S. Stone W. J. : “Comparably Massive” Penicillin G Therapy in Renal Failure, Ann. Intern. Med. 82: 189–195 (Feb.) 1975.

Latos D. L. Bryan C. S. Stone W. J. : Carbenicillin Therapy in Patients with Normal and Impaired Renal Function, Clin. Pharmacol. Ther. 17: 692–700 (June) 1975.

Spyker D. A. Guenant R. L. : Gentamicin Dosage, Ann. Intern. Med. 86: 357–358 (Mar.) 1977.

Henry J. B. : op. cit. p. 1378.